What are the risks associated with lipiodol hysterosalpingography? A literature review
Authors:
Open Access
- 13 September 2023
- journal article
- review article
- Published by Elsevier in Radiography
- Vol. 29 (6) , 1041-1045
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Iodinated contrast–induced thyrotoxicosisCanadian Medical Association Journal, 2012
- Thyroid function after hysterosalpingography using an oil-soluble iodinated contrast mediumGynecological Endocrinology, 2008
- After the FLUSH trial: A prospective observational study of lipiodol flushing as an innovative treatment for unexplained and endometriosis‐related infertilityAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2006
- Pulmonary and cerebral oil embolism after hysterosalpingography with oil soluble contrast mediumRespirology, 2004
- Safety and Pharmacokinetics of Iotrolan in HysterosalpingographyInvestigative Radiology, 1995
- Adverse Reactions to Lipiodol Ultra Fluid:Report of an Accidental Case.The Keio Journal of Medicine, 1991
- Pregnancy Rates After the Use of Oil-Based and Water-Based Contrast Media to Evaluate Tubal PatencySouthern Medical Journal, 1990
- Retinal embolism after hysterosalpingography.British Journal of Ophthalmology, 1973
- Hysterosalpingography and Infertility*Australian and New Zealand Journal of Obstetrics and Gynaecology, 1965
- HYSTEROSALPINGOGRAPHY IN FEMALE INFERTILITY: A COMPARISON OF LIPIODOL AND VISKIOSOL SIXThe Lancet, 1952